{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:47:33Z","timestamp":1791827253488,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"am","delay-in-days":642,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejmech.2022.114573","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T04:15:35Z","timestamp":1656648935000},"page":"114573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors"],"prefix":"10.1016","volume":"240","author":[{"given":"Camille","family":"Hauguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ducellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Provot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coline","family":"Balcerowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Letribot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megane","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Askenatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Levaique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Bauvais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bollot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolor","family":"Renko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Deroussent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Catherine","family":"Laisne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lafanech\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Papot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Montagnac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouad","family":"Alami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Apcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-1971","authenticated-orcid":false,"given":"Abdallah","family":"Hamze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114573_bib1","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2022.114573_bib2","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/17460441.2.6.799","article-title":"How to design multi-target drugs","volume":"2","author":"Korcsm\u00e1ros","year":"2007","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114573_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2022.114573_bib5","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.201600161","article-title":"Multitarget drug discovery and polypharmacology","volume":"11","author":"Bolognesi","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114573_bib7","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2174\/1389557516666160505115324","article-title":"Indole based tubulin polymerization inhibitors: an update on recent developments","volume":"16","author":"Sunil","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib8","first-page":"4510","article-title":"Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4","volume":"58","author":"Iyer","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114573_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.bjc.6692174","article-title":"In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug","volume":"81","author":"Grosios","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2022.114573_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1470-2045(00)00224-2","article-title":"Targeting tumour vasculature: the development of combretastatin A4","volume":"2","author":"Griggs","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2022.114573_bib11","series-title":"Comprehensive Natural Products II","first-page":"5","article-title":"2.02 - terrestrial plants as a source of novel pharmaceutical agents","author":"Cragg","year":"2010"},{"key":"10.1016\/j.ejmech.2022.114573_bib12","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm0205797","article-title":"Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-Combretastatin A-4","volume":"48","author":"Pettit","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib13","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/S0960-894X(98)00579-4","article-title":"Syntheses and antitumor activity of cis-restricted combretastatins: 5-Membered heterocyclic analogues","volume":"8","author":"Ohsumi","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114573_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejmech.2007.03.030","article-title":"Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents","volume":"43","author":"Bekhit","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib15","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/jm900321u","article-title":"Isocombretastatins A versus combretastatins A: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent","volume":"52","author":"Messaoudi","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib16","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/cmdc.200900290","article-title":"Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents","volume":"4","author":"Hamze","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114573_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/nn500517a","article-title":"Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy","volume":"8","author":"Maksimenko","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2022.114573_bib18","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2174\/187152061310131206162302","article-title":"Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization","volume":"13","author":"Provot","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cmdc.201000456","article-title":"Discovery of isoerianin analogues as promising anticancer agents","volume":"6","author":"Messaoudi","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114573_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2014.03.032","article-title":"Discovery of azaisoerianin derivatives as potential antitumors agents","volume":"78","author":"Soussi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112110","article-title":"Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents","volume":"190","author":"Hamze","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejmech.2019.02.038","article-title":"N,N-bis-heteroaryl methylamines: potent anti-mitotic and highly cytotoxic agents","volume":"168","author":"Khelifi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/cmdc.201500069","article-title":"IsoCombretaQuinazolines: potent cytotoxic agents with antitubulin activity","volume":"10","author":"Soussi","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114573_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ejmech.2016.11.012","article-title":"Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors","volume":"127","author":"Khelifi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib25","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1021\/acs.jmedchem.8b01386","article-title":"1,1-Diheterocyclic ethylenes derived from quinaldine and carbazole as new tubulin-polymerization inhibitors: synthesis, metabolism, and biological evaluation","volume":"62","author":"Naret","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114573_bib27","series-title":"Advances in Cancer Research","first-page":"137","article-title":"Histone deacetylase inhibitors","author":"Marks","year":"2004"},{"key":"10.1016\/j.ejmech.2022.114573_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2022.114573_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.578770","article-title":"Histone deacetylases and histone deacetylase inhibitors in neuroblastoma","volume":"8","author":"Phimmachanh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2022.114573_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17460441.2020.1736032","article-title":"How do we improve histone deacetylase inhibitor drug discovery?","volume":"15","author":"Hamze","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114573_bib31","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.7150\/thno.26627","article-title":"Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling","volume":"8","author":"Huang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2022.114573_bib32","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1021\/acs.jmedchem.8b00050","article-title":"Design and synthesis of tubulin and histone deacetylase inhibitor based on iso-combretastatin A-4","volume":"61","author":"Lamaa","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib33","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.bmcl.2019.07.045","article-title":"Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors","volume":"29","author":"Wang","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114573_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-015-0176-7","article-title":"The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo","volume":"8","author":"Chao","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2022.114573_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105625","article-title":"2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response","volume":"120","author":"Sun","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113790","article-title":"Discovery of novel tubulin\/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency","volume":"225","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib37","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1021\/acs.jmedchem.1c00413","article-title":"Efficient synthesis and bioevaluation of novel dual tubulin\/histone deacetylase 3 inhibitors as potential anticancer agents","volume":"64","author":"Peng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib38","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1002\/chem.201501050","article-title":"Stereo-retentive palladium-catalyzed arylation, alkenylation, and alkynylation of 1-thiosugars and thiols using aminobiphenyl palladacycle precatalyst at room temperature","volume":"21","author":"Bruneau","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2022.114573_bib39","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1021\/jo401217x","article-title":"Csp 2-N Bond formation via ligand-free Pd-catalyzed oxidative coupling reaction of N-tosylhydrazones and indole derivatives","volume":"78","author":"Roche","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib40","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1021\/jo501315q","article-title":"Tandem one-pot palladium-catalyzed coupling of hydrazones, haloindoles, and amines: synthesis of amino-N-vinylindoles and their effect on human colon carcinoma cells","volume":"79","author":"Roche","year":"2014","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.tetlet.2007.12.057","article-title":"One-pot hydrosilylation-protodesilylation of functionalized diarylalkynes: a highly selective access to Z-stilbenes. Application to the synthesis of combretastatin A-4","volume":"49","author":"Giraud","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114573_bib42","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib43","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/cmdc.201100325","article-title":"B-Ring-Modified isoCombretastatin A-4 analogues endowed with interesting anticancer activities","volume":"6","author":"Hamze","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114573_bib44","first-page":"71","article-title":"Stable combretastatin A-4 analogues with sub-nanomolar efficacy against chemoresistant HT-29 cells","volume":"49","author":"Schobert","year":"2011","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejmech.2022.114573_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2016.11.088","article-title":"The role of mitochondria in metabolism and cell death","volume":"482","author":"Vakifahmetoglu-Norberg","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2022.114573_bib46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","article-title":"The multifaceted contributions of mitochondria to cellular metabolism","volume":"20","author":"Spinelli","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114573_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0008-6363(00)00002-X","article-title":"Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes","volume":"46","author":"Mathur","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2022.114573_bib48","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/acsmedchemlett.8b00440","article-title":"Extending cross metathesis to identify selective HDAC inhibitors: synthesis, biological activities, and modeling","volume":"10","author":"Bouchet","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114573_bib49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/414660a","article-title":"AID is required to initiate Nbs1\/\u03b3-H2AX focus formation and mutations at sites of class switching","volume":"414","author":"Petersen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114573_bib50","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib51","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/1078-0432.CCR-04-2088","article-title":"Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity","volume":"11","author":"Munshi","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114573_bib52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/0008-5472.CAN-03-2630","article-title":"Enhanced radiation-induced cell killing and prolongation of \u03b3H2AX foci expression by the histone deacetylase inhibitor MS-275","volume":"64","author":"Camphausen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114573_bib53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fphar.2020.00543","article-title":"A new quantitative cell-based assay reveals unexpected microtubule stabilizing activity of certain kinase inhibitors, clinically approved or in the process of approval","volume":"11","author":"Ramirez-Rios","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114573_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112873","article-title":"Cyclic bridged analogs of isoCA-4: design, synthesis and biological evaluation","volume":"209","author":"Pecnard","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx683","article-title":"Intratumoral immunotherapy: using the tumor as the remedy","volume":"28","author":"Marabelle","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2022.114573_bib56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1470-2045(17)30231-0","article-title":"Ipilimumab 10 mg\/kg versus ipilimumab 3 mg\/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial","volume":"18","author":"Ascierto","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2022.114573_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s42003-021-01801-2","article-title":"Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens","volume":"4","author":"Darrigrand","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2022.114573_bib58","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/jm801315b","article-title":"Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration","volume":"52","author":"Sirisoma","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114573_bib59","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1093\/emboj\/17.16.4668","article-title":"The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression","volume":"17","author":"Venot","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2022.114573_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.200512058","article-title":"Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends","volume":"174","author":"Peris","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114573_bib61","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.tet.2013.02.061","article-title":"Insight into the palladium-catalyzed oxidative arylation of benzofuran: heteropoly acid oxidants evoke a Pd(II)\/Pd(IV) mechanism","volume":"69","author":"Pereira","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114573_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31154-6","article-title":"Instant Clue: a software suite for interactive data visualization and analysis","volume":"8","author":"Nolte","year":"2018","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:41:18Z","timestamp":1759329678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422004755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":62,"alternative-id":["S0223523422004755"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114573","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114573"}}